Stock MNMD MIND MEDICINE (MINDMED) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Mind Medicine (MindMed) Inc.

Equities

MNMD

CA60255C8850

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
8.46 USD -4.62% Intraday chart for Mind Medicine (MindMed) Inc. -11.23% +131.15%
Apr. 15 Leerink Partners Starts Mind Medicine (MindMed) With Outperform Rating, $20 Price Target MT
Mar. 18 Mind Medicine Inc. announced that it has received $75 million in funding from Deep Track Capital, LP, Commodore Capital CI

Evolution of the average Target Price on Mind Medicine (MindMed) Inc.

Price target over the last 5 years

History of analyst recommendation changes

4d5c1808938.KnUvOiPHTbEte4rJetAhe8cMK4zkFuIr-Tm6u42Y1KA.biBwdEaCNOBkKfi9SYJCCpdJHaGCL6dmpnKOwdv7gdYaE1VLE_J76VdMxw~50ef67b3d3e4f5f17a98e987ebfa44d0

Analyst Recommendations on Mind Medicine (MindMed) Inc.

Leerink Partners Starts Mind Medicine (MindMed) With Outperform Rating, $20 Price Target MT
RBC Raises Price Target on Mind Medicine (MindMed) to $22 From $15, Keeps Outperform, Speculative Risk MT
Roth MKM Raises Price Target on Mind Medicine to $36 From $25, Keeps Buy Rating MT
RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept MT
RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk MT
EF Hutton Initiates Mind Medicine at Buy With $21 Price Target MT
Mind Medicine (MindMed) Initiated at Outperform by RBC With $5 Price Target, Speculative Risk Qualifier; Firm Sees 'Opportunity for Upside' MT
HC Wainwright Adjusts Mind Medicine's Price Target to $75 from $5, Retains Buy Rating MT
Oppenheimer Initiates Coverage on Mind Medicine With Outperform Rating, $3.50 Price Target MT
HC Wainwright Adjusts Mind Medicine's Price Target to $5 From $10, Maintains Buy Rating MT
Cantor Fitzgerald Starts Mind Medicine at Overweight With $3 Price Target MT
Roth Capital Starts MindMed at Buy With $7 Price Target MT
MIND MEDICINE MINDMED : HC Wainwright Starts MindMed at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.46 USD
Average target price
30.86 USD
Spread / Average Target
+264.74%
High Price Target
75 USD
Spread / Highest target
+786.52%
Low Price Target
16 USD
Spread / Lowest Target
+89.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Mind Medicine (MindMed) Inc.

Leerink Partners
RBC Capital Markets
Roth MKM
EF Hutton
HC Wainwright
Oppenheimer
Cantor Fitzgerald
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MNMD Stock
  4. Consensus Mind Medicine (MindMed) Inc.